CAIR2 Currently Supports Meaningful Use Stage 3

On July 1, 2017, California Immunization Registry (CAIR2) declared its readiness to support Stage 3 of the Meaningful Use program, including the ability to receive patient queries and return patient histories and/or recommendations as well as the ability to receive National Drug Codes (NDC) for newly–administered immunizations. Guidance on message formatting is available in the CDC HL7 2.5.1 Implementation Guide for Immunization Messaging, Release 1.5 and Addendum. Consult with your vendor to determine whether your EHR is ready for Stage 3. If your site is interested in Stage 3, which requires bi-directional data exchange (BiDX) with CAIR2 as well as demonstrated ability to submit NDC vaccine codes, please complete the CAIR2 Bi-directional Interest/Readiness Survey. The self-directed CAIR2 bi-directional onboarding (testing) process is available now. Note: in addition to bi-directional messaging, providers must maintain ongoing submission of patient data in order to fulfill the receive the Stage 3 immunization reporting requirement.